日本語 >>
TOP page
Present specialized field
Journal
Presentation
（Last updated : 2026-05-25 11:23:09）
Seiji Itano
Department
Kawasaki Medical School Kawasaki Medical School, Department of Nephrology and Hypertension,
Position
Assistant Professor
■
Present specialized field
Nephrology
■
Journal
1.
2025/11/18
Proteinuria reduction as a surrogate endpoint for clinical study of IgA nephropathy in Japanese patients: data from the J-CKD-DB-Ex
2.
2023/07/19
eGFR slope as a surrogate endpoint for clinical study in early stage of chronic kidney disease: from The Japan Chronic Kidney Disease Database
3.
2024/07/06
Guidelines for clinical evaluation of chronic kidney disease in early stages : AMED research on regulatory science of pharmaceuticals and medical devices.
4.
2020/11/03
Association of Arterial Stiffness With Kidney Function Among Adults Without Chronic Kidney Disease.
5.
2020/11/01
Non-purine selective xanthine oxidase inhibitor ameliorates glomerular endothelial injury in InsAkita diabetic mice.
6.
2017/05/02
Colchicine attenuates renal fibrosis in a murine unilateral ureteral obstruction model.
7.
2013/03
A case of drug-induced granulomatous interstitial nephritis during the long course of Crohn's disease
8.
2021/11/03
Laxative use and mortality in patients on haemodialysis: a prospective cohort study.
9.
2019/11
Bardoxolone methyl analog attenuates proteinuria-induced tubular damage by modulating mitochondrial function.
10.
2021/08
A rare case of amyloid light-chain amyloidosis with bilateral perirenal hematoma shortly after initiation of peritoneal dialysis.
11.
2019/01
5-Aminolevulinic acid exerts renoprotective effect via Nrf2 activation in murine rhabdomyolysis-induced acute kidney injury.
12.
2018/05/09
Distinct characteristics and outcomes in elderly-onset IgA vasculitis (Henoch-Schönlein purpura) with nephritis: Nationwide cohort study of data from the Japan Renal Biopsy Registry (J-RBR)
13.
2017/08
Infiltration of M1, but not M2, macrophages is impaired after unilateral ureter obstruction in Nrf2-deficient mice.
14.
2025/10
Efficacy of a mobile health application on self-management among Japanese patients with chronic
kidney disease.
15.
2024/11/02
ASK-1 activation exacerbates kidney dysfunction via increment of glomerular permeability and accelerates cellular aging in diabetic kidney disease model mice
16.
2024/04/11
Development of a prognostic risk score to predict early mortality in incident elderly Japanese hemodialysis patients.
17.
2024/01/09
A case series of Fabry diseases with CKD in Japan.
18.
2023/06
The Impact of Potassium Binders on Mortality in Patients with Hyperkalemia: A Single-Center Study
19.
2023/01/25
Drug-induced acute kidney injury
20.
2022/08/10
Retrospective study on changes in renal function by treatment with two types of herbal medicines
21.
2022/03/23
A case of pleuroperitoneal communication during long-term steroid therapy for dermatomyositis
22.
2021/05/11
Effect of zinc deficiency on chronic kidney disease progression and effect modification by hypoalbuminemia.
23.
2018/10/03
The eNOS-NO pathway attenuates kidney dysfunction via suppression of inflammasome activation in aldosterone-induced renal injury model mice.
24.
2016/05/23
Feasibility of fluorescence energy transfer system for imaging the renoprotective effects of aliskiren in diabetic mice.
25.
2016/02
Prevalence of gastroesophageal reflux disease symptoms and effects of esomeprazole on the quality of life related to reflux and dyspepsia in patients on maintenance hemodialysis.
26.
2013/09
Allergic reaction to polysulfone membrane dialyzer in a hemodialysis patient
27.
2013/05
A case of crescentic poststreptococcal acute glomerulonephritis (PSAGN) accompanied by membranous nephropathy
28.
2013/01
Hyponatremia associated with demyelinating disease of the nervous system
29.
2012/10
Clinical characteristics adult-onset minimal change nephrotic syndrome in our hospital
30.
2012/05
A case of anti-GBM glomerulonephritis and membranous nephropathy in a patient with primary biliary cirrhosis
31.
2011
A novel mutation ApoE2 Kurashiki (R158P) in a patient with lipoprotein glomerulopathy.
Display 5 items
Display all(31)
■
Presentation
1.
2026/03/29
Effectiveness of zinc acetate hydrate supplementation for kidney outcomes in patients with chronic kidney disease and hypozincemia: ZAK-CKD study （Poster notice，General）
2.
2026/03/29
Protein Reduction as a Surrogate Endpoint for Clinical Study of IgA Nephropathy in Japanese Patients: Data from the J-CKD-DB-Ex （Poster notice，General）
3.
2024/09/14
Podocyte damage observed in neuronal intranuclear inclusion body disease （Poster notice，General）
4.
2020/10/19
Effect of Zinc Deficiency on CKD Progression and Effect Modification by Hypoalbuminemia. （Poster notice，General）
5.
2020/10/19
Machine Learning Prediction of ESKD and Death in CKD Patients: Electronic Medical Record-Based Cohort Study. （Poster notice，General）
6.
2020/06/07
ASSOCIATION BETWEEN THE USE OF DRUGS FOR CONSTIPATION AND MORTALITY IN HEMODIALYSIS PATIENTS; FROM JAPAN-DIALYSIS OUTCOMES AND PRACTICE PATTERNS STUDY (J-DOPPS) （Speech，General）
7.
2020/06/07
KEAP1/NRF2 PATHWAY REGULATES GFR BY INCREASING THE GLOMERULAR EFFECTIVE AREA WITHOUT AFFECTING THE AFFERENT/EFFERENT ARTERIOLE RATIO （Poster notice）
8.
2020/02/15
Zinc deficiency is a risk factor for chronic kidney disease progression （Speech，General）
9.
2019/11/09
Development of an Exhaustive-Risk-Prediction System Using Deep Learning and Different Patterns of Diabetic Kidney Disease Progression Based on Patient Characteristics （Poster notice，General）
10.
2019/11/08
Association of Arterial Stiffness with Kidney Function Among Adults Without CKD （Poster notice，General）
11.
2019/04/12
Effect of uremic toxin-indoxcyl sulfate on intestinal defensin expression in renal failure mice. （Poster notice，General）
12.
2018/10/25
Uremic Toxin Decreases Intestinal Defense Peptides and Barrier Functions in Chronic Renal Failure Mice （Poster notice，General）
13.
2018/02/22
5-aminolevulinic acid exerts renoprotective effect via Nrf2 activation in rhabdomyolysis-induced acute kidney injury . （Poster notice，General）
14.
2018/02/22
Diagnosis of a case of anti-neutrophil cytoplasmic antibody associated Glomerulonephritis during a school health examination. （Poster notice，General）
15.
2018/02/22
eNOS -NO signaling attenuates renal fibrosis via suppression of catenin signaling. （Poster notice，General）
16.
2018/02/22
Membranous nephropathy diagnosed in the early stages of pregnancy :A case report. （Poster notice，General）
17.
2018/02/22
Non-purine selective xanthine oxidase inhibitor ameliorates glomerular endothelial injury in Ins2Akita diabetic mice. （Poster notice，General）
18.
2018/02/22
RTAdh404 attenuates renal inflammation and fibrosis via mitochondrial protection in ICGN mice. （Poster notice，General）
19.
2018/02/22
The association of microbiota alteration and intestinal barrier function in chronic renal failure mice. （Poster notice，General）
20.
2018/02/22
The eNOS/NO signaring attenuates glomerular injury in diabetic mice via suppression of inflammasome activation. （Poster notice，General）
21.
2017/09/15
Evaluation of the effect of empagliflozin on improving hyperfiltration in diabetic nephropathy （Speech，General）
22.
2017/06/05
ENOS/NO Signaling Attenuates Glomerular Injury in Diabetic Mice via Suppression of Inflammasome Activation. （Poster notice，General）
23.
2016/11/17
Nrf2 Dependent Inflmmasome Activation Contributes to Maintain M1 Macrophage but Not M2 Infiltration in Kidney Disease Model . （Poster notice，General）
24.
2016/11/16
eNOS-NO Pathway Attenuates Chronic Inflammation via Nitric Oxide in Hypertensive Kidney Disease. （Poster notice，General）
25.
2016/09/27
Activation of Endothelial NAD(P)H Oxidase Accelerates Early Glomerular Injury in Diabetic Mice. （Poster notice，General）
26.
2016/09/27
Feasibility of Fluorescence Energy Transfer System for Imaging the Renoprotective Effects of Aliskiren in Diabetic Mice. （Poster notice，General）
27.
2016/09/26
Cyclic GMP Dependent Protein Kinase-AKT Pathway is Essential for Compensatory Renal Hypertrophy and Maintenance Renal Function After Unilateral Nephrectomy. （Poster notice，General）
28.
2016/09/26
Renal Denervation Protects Renal Function by Suppressing NAD(P)H Oxidase Activity in Dahl Salt-Sensitive Rats. （Poster notice，General）
29.
2016/09/18
Effects of Lanthanum Carbonate on Intestinal Bacterial Flora and Intestinal Barrier Function in Chronic Renal Failure Mice （Poster notice，General）
30.
2016/05/31
Feasibility of Fluorescence Energy Transfer System for Imaging the Renoprotective Effects of Aliskiren in Diabetic Mice. （Poster notice）
31.
2016/02/27
Effects of Lanthanum Carbonate on Intestinal Bacterial Flora and Intestinal Barrier Function in Chronic Renal Failure Mice （Speech，General）
32.
2015/11/06
Effects of Lanthanum Carbonate on Intestinal Bacterial Flora in Chronic Renal Failure Mice. （Poster notice，General）
33.
2015/11/05
Possible Implication of Xanthine Oxidase Activation on the Pathogenesis Diabetic Nephropathy. （Poster notice，General）
34.
2015/09/25
Possible implication of xanthine oxidase activation on the pathogenesis diabetic nephropathy. （Poster notice，General）
35.
2015/09/25
Visualization of in vivo renin activity and its application to study the pathogenetic mechanisms of diabetic nephropathy （Poster notice，General）
36.
2015/03/16
Low-Dose Colchicine Treatment Attenuates Renal Fibrosis in Mice Unilateral Ureteral Obstruction. （Poster notice，General）
37.
2015/02/28
Protective role of klotho protein on peritoneal membrane via suppression of wnt/B-catenin signaling in mice. （Speech，General）
38.
2014/11/15
Klotho Overexpression Attenuates Peritoneal Fibrosis via Suppression of Wnt/B-Catenin Signaling Pathway in Mice （Speech，General）
39.
2014/11/14
Enhancement of Wnt/B-Catenin Signaling Promotes Renal Fibrosis by Inducing Cell Cycle Arrest at the G2/M Phase in Tubular Epithelial Cells （Poster notice，General）
40.
2014/10/17
Development of a Novel In Vivo-Imaging Technique to Detect Renin-Activity in an Attempt to Elucidate Reno-Protective Effects of Calcium-Channel Blocker （Poster notice，General）
41.
2014/10/17
Molecular Mechanisms of Aldosterone-Induced Renal Interstitial Fibrosis and Ameliorative Effects of Mineralocorticoid Receptor Antagonist （Speech，General）
42.
2014/06/01
The Effect of Azelnizipine on Tissue/Plasma Renin Activity in mice with Diabetic Nephropathy. （Poster notice，General）
43.
2014/05/15
Benidipine Attenuates Albuminuria Through Amelioration of Enos Uncoupling in Hypertensive Kidney Disease Model. （Poster notice，General）
44.
2013/11/07
T Type Ca-Channel Blocker Exerts Anti-Albuminuic Effect through Amelioration of eNOS Uncoupling in Hypertensive Kidney Disease Model. （Poster notice，General）
45.
2013/10/26
Molecular Mechanism of Mineralocorticoid Receptor Antagonist on Suppressive Effects of Inflammasome Activation by Aldosterone. （Poster notice，General）
46.
2013/10/24
Investigation for the Mechanisms of Anti-albuminuic Effects of T Type Ca-channel Blocker through Amelioration of eNOS Uncoupling. （Speech，General）
47.
2013/10/24
Islet Microangiopathy in Hypertensive Rats and the Protective Effects of ARB on the Islet Morphology. （Speech，General）
48.
2013/06/02
Implications of Inflammasome-Activation in Macrophage on the Development of Renal Interstitial Inflammation and Fibrosis in Mice. （Poster notice，General）
49.
2013/06/01
Klotho Protein Ameliorates Peritoneal Fibrosis Though The Regulation of Wnt/B-Catenin Signaling. （Poster notice，General）
50.
2013/06/01
Rosuvastatin Maintain Glomerular Endothelial Surface layer Through Nrf2 Activation in Mouse Diabetic Nephropathy. （Poster notice，General）
Display 5 items
Display all(50)
